Topline Results from Phase 3 Trials of Fezolinetant for Treatment of Vasomotor Symptoms
Samuel Lederman, obstetrician, gynecologist, and a founding member of Palm Beach Obstetrics & Gynecology, discusses the positive 12-week primary analysi...
39 articles
Samuel Lederman, obstetrician, gynecologist, and a founding member of Palm Beach Obstetrics & Gynecology, discusses the positive 12-week primary analysi...
James Sapirstein, President and CEO of AzurRX BioPharma, Inc., a developer of targeted therapies for gastrointestinal (GI) diseases, discusses the conti...
Sinai, New York discusses Janssen's announcement of their new two-year data from the long-term extension of the Phase 3 UNIFI study of STELARA® (usteki...
Heidi Godoy discusses what it means to have ovarian cancer, the latest in treatment options for recurrent ovarian cancer and how they work. She encour...
Elizabeth Cherot talks about advances in opioid alternatives, shares what she’s doing to help her patients and encourages women to speak with their do...
Ed Sandrick, Director of the Veterans Channel for Humana, shares helpful information for veterans to better understand how a Medicare Advantage plan can...
Jochen Knolle, CSO, discuss Pharvaris, a clinical-stage company focused on developing oral therapies for hereditary angioedema (HAE) patients.
Grammy winner and breast cancer survivor Sheryl Crow is here to share her experience and share with other women the importance of screening. Dr.
For World Heart Day 2019 Amgen released findings from a global survey of heart attack survivors. Dr. Learn more on Health Professional Radio.
Karen Cox, president of Chamberlain University discusses the latest statistics on the current and projected nursing shortage, how to structure a nursing...